as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹30.64
Change
+0.26 (0.86%)
Open
₹30.3
Prev. Close
₹30.38
Day High
₹30.75
Day Low
₹30.13
Volume Analysis
Traded
364,536
Delivered
212,264
Delivery %
58.23%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹31.51 | ₹31.13 | ₹30.89 | ₹30.51 | ₹30.27 | ₹29.89 | ₹29.65 |
| Fibonacci | ₹31.13 | ₹30.89 | ₹30.75 | ₹30.51 | ₹30.27 | ₹30.13 | ₹29.89 |
| Camarilla | ₹30.81 | ₹30.75 | ₹30.7 | ₹30.51 | ₹30.58 | ₹30.53 | ₹30.47 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-3.68%
1 Week
-1.38%
1 Month
+6.54%
3 Months
-2.54%
6 Months
-0.71%
1 Year
-6.27%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Icicimom30 lands in the middle of the pack on TopFund's composite fundamentals check, at 52/100. The strongest factor is Risk & Volatility (62/100), while Liquidity (39/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
52/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Icicimom30?
Frequently Asked Questions about Icicipramc - Icicimom30
Icicipramc - Icicimom30 (MOM30IETF) closed at ₹30.64 on NSE on 19 November 2026, up 0.26 (0.86%) from the previous close.
Icicipramc - Icicimom30 trades on the NSE (National Stock Exchange of India) under the symbol MOM30IETF.
Icicipramc - Icicimom30 has a TopFund Quality Score of 52/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Icicimom30?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.